Adaptive Biotechnologies Corp (ADPT)

Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.96%71.55	70.87	71.68	93.97	58.88
Cost Of Revenue	7.79%20.17	18.71	18.22	18.16	18.00
	18.92%19.15	23.62	-	-	-
Research and Development	18.92%19.15	23.62	-	-	-
Interest Income/Expense	6.75%2.69	2.89	2.95	2.97	2.95
Costs And Expenses	3.06%87.32	90.08	84.45	83.68	83.92
Operating Income/Loss	17.89%-15.77	-19.21	-12.77	10.29	-25.04
	99.56%-39.94	-20.02	-13.58	9.55	-25.59
Attributable To Parent	98.61%-39.79	-20.03	-13.58	9.55	-25.61
Attributable To Noncontrolling Interest	950.00%-0.15	0.02	-	-0.00	0.02
Basic Average Shares	2.79%159.86	155.52	0.47	152.43	152.08
Diluted Average Shares	2.79%159.86	155.52	0.47	163.16	152.08
Basic Earnings Per Share	92.31%-0.25	-0.13	-0.09	0.06	-0.17
Diluted Earnings Per Share	92.31%-0.25	-0.13	-0.09	0.06	-0.17